Walking Pads Are a $1.4 Billion Category Now and the Health Data Is Better Than Critics Thought

The walking pad category, meaning compact under-desk treadmills built for use while working, crossed $1.4 billion in U.S. annual sales in 2025 and is on track for $1.8 billion in 2026, according to NPD Group data shared with Retail Dive in February. Three years ago the category was under $200 million. The growth came from remote and hybrid work, the price point dropping from above $700 to between $180 and $450 for most consumer models, and consistent video content from creators including Cassey Ho and Caroline Girvan.

The first wave of skepticism around walking pads came from cardiologists who pointed out that walking at 1.5 to 2.5 miles per hour, the typical pace at a desk, sits below the threshold for traditional cardiovascular benefit. That critique is technically true but incomplete. A January 2026 study in the British Journal of Sports Medicine, drawing on 612 adults using walking pads four to six hours per day, found that participants accumulated an average of 11,400 steps on workdays compared to 4,200 on baseline days. Total daily energy expenditure rose by 312 calories.

The most useful finding in the BJSM data was on glucose response. Participants who walked while working showed average post-meal glucose levels 18 percent lower than the same participants on seated days. The effect held across breakfast and lunch responses. The mechanism is straightforward. Walking activates skeletal muscle uptake of glucose without requiring high intensity. The slow continuous movement through the post-meal window pulls glucose into the muscle rather than letting it sit in circulation.

For people with insulin resistance or pre-diabetes, that finding is meaningful. The University of Texas Southwestern ran a parallel six-week trial in 2025 with 84 pre-diabetic adults assigned either to standing desks or walking pads at 1.8 mph for four hours per workday. The walking pad group reduced fasting glucose by an average of 9 percent compared to the standing group at 6 percent. Both outperformed a seated control group. HbA1c improvements were modest in the short window but trending favorable.

The cognitive question is the one most office workers ask first. Does walking while working hurt focus? The research suggests it depends on the task. A Stanford lab in 2024 ran a comparison study showing that creative ideation, brainstorming, and call-based work performed equally or slightly better while walking versus seated. Detail-heavy tasks like spreadsheet work, code review, and editing showed a 6 to 11 percent slowdown while walking. Most users in the BJSM study reported using walking time for meetings and reading, which fits the productivity pattern.

The injury concern is a real one and the research has tightened over the last year. The most common complaint among walking pad users in the first 90 days is anterior shin splints, sometimes from poor footwear and sometimes from gait changes that come with walking on a moving belt. A March 2026 review in the Journal of Orthopaedic and Sports Physical Therapy found that walking pad users wearing zero-drop or minimal shoes had a 3.2 times higher rate of shin pain than users wearing standard cushioned shoes. The simple recommendation from the JOSPT authors was to keep regular sneakers at the desk.

The product market itself has consolidated faster than expected. WalkingPad, the original Chinese brand owned by Kingsmith, holds roughly 38 percent of U.S. category sales. Sperax, Goyouth, and a wave of Amazon-only brands hold most of the rest. Higher-end entrants from Lifespan and iMovr have pushed up into the $700 to $1,400 range with whisper-quiet motors and incline functions. The Lifespan Glowpad, released in October 2025, has been the standout review unit of the cycle. Wirecutter put it at the top of its 2026 walking pad guide.

There is a growing employer benefit angle. Microsoft, Salesforce, and Atlassian have begun reimbursing walking pads through their wellness benefits at $250 to $500 per employee, similar to the way they reimburse standing desks. Aetna and a few other large insurers have started piloting walking pad coverage for pre-diabetic plan members. The case for employer adoption is strong because the upfront cost is low, the device fits into a closet when not in use, and the glucose data is concrete enough to interest medical directors.

For someone considering a walking pad, the practical advice from the research is to start at one to two hours per day at 1.5 to 2 mph. Build up to four hours per day over a month. Use cushioned sneakers, not slippers. Keep the desk at standing height and rotate between walking, standing still, and sitting throughout the day. The accumulated steps and the post-meal glucose effects are the two clearest payoffs. Heart-rate-zone benefits require separate dedicated cardio sessions, which the walking pad does not replace.